Effect of erdosteine in moderately severe COPD patients

P. Calverley (Aintree, United Kingdom), C. Page (London, United Kingdom), R. Dal Negro (Verona, Italy), G. Fontana (Firenze, Italy), M. Iversen (Copenhagen, Denmark), A. Cicero (Bologna, Italy), E. Pozzi (Paderno Dugnano, Italy), J. Wedzicha (London, United Kingdom)

Source: International Congress 2018 – Pharmacological management of COPD
Session: Pharmacological management of COPD
Session type: Thematic Poster
Number: 776
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Calverley (Aintree, United Kingdom), C. Page (London, United Kingdom), R. Dal Negro (Verona, Italy), G. Fontana (Firenze, Italy), M. Iversen (Copenhagen, Denmark), A. Cicero (Bologna, Italy), E. Pozzi (Paderno Dugnano, Italy), J. Wedzicha (London, United Kingdom). Effect of erdosteine in moderately severe COPD patients. 776

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: